Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

FOLFIRI regimen

View Patient Information
A regimen consisting of leucovorin calcium (calcium folinate), 5-fluorouracil, and irinotecan that can be used in the treatment of appendiceal, small bowel, pancreatic and occult primary adenocarcinoma; colorectal, esophageal and esophagogastric junction, gastric, and hepatobiliary cancers; well-differentiated grade 3 neuroendocrine tumors (NETs), and extrapulmonary poorly differentiated neuroendocrine carcinoma, large or small cell carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:fluorouracil-folinic acid-irinotecan
fluorouracil/folinic acid/irinotecan
fluorouracil/leucovorin/irinotecan
FOLinic acid-fluorouracil-IRInotecan regimen
folinic acid/fluorouracil/irinotecan regimen
Abbreviation:FOLFIRI
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search